Merck Competitors and Similar CompaniesClear all
Trulieve's competitors and similar companies include Bausch Health, Sanofi, Zoetis, GSK, Eli Lilly, Johnson & Johnson, Bayer, Pfizer, CVS Health, Merck Group and Teva Pharmaceuticals.
 Bausch Health Bausch Health is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products. |  Sanofi Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. |  Zoetis Zoetis (formerly known as Pfizer Animal Health) is an animal health company focusing on the discovery, development, manufacture, and commercialization of medicines, vaccines, and diagnostic products and services. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. |  Eli Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. |  Johnson & Johnson Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ||||||
Founding Date | Founding Date 2016 | Founding Date 1959 | Founding Date 2004 | Founding Date 1952 | Founding Date 2000 | Founding Date 1876 | Founding Date 1886 | Founding Date 1863 | Founding Date 1849 | Founding Date 1963 | Founding Date 1668 | Founding Date 1901 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||||||||
Locations | Locations North Fort Myers, US HQ Bradenton, US Edgewater, US Jacksonville, US Miami, US Orlando, US Pensacola, US see more | Locations Laval, CA HQ Buenos Aires, AR Wien, AT Sarajevo, BA Indaiatuba, BR Porto Alegre, BR Sao Paulo, BR see more | Locations Parsippany, US HQ Buenos Aires, AR Villa Adelina, AR Silverwater, AU Wien, AT Ottignies Louvain La Neuve, BE Zaventem, BE see more | Locations Brentford, GB HQ Boumerdes, DZ San Fernando, AR Abbotsford, AU Boronia, AU Ermington, AU Wien, AT see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more | Locations New Brunswick, US HQ Buenos Aires, AR Sydney, AU Ultimo, AU Wien, AT Minsk, BY Beerse, BE see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Bentley, AU Footscray, AU Mulgrave, AU Sydney, AU see more | Locations Woonsocket, US HQ Irving, US Northbrook, US Pittsburgh, US Scottsdale, US | Locations Darmstadt, DE HQ Buenos Aires, AR Bayswater, AU Macquarie Park, AU Wien, AT Hoeilaart, BE Rio De Janeiro, BR see more | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | ||
Employees | Employees 4,455 | Employees 20,270 | Employees 86,088 | Employees 14,1002% increase | Employees 70,212 | Employees 39,00011% increase | Employees 131,90014% decrease | Employees 94,2454% decrease | Employees 83,0005% increase | Employees 300,000 | Employees 62,176 | Employees 37,0006% increase |
Valuation ($) | Valuation ($) 2.2 b | Valuation ($) 3 b | Valuation ($) 141.1 b | Valuation ($) 82.1 b | Valuation ($) 862.5 m | Valuation ($) 903.4 b | Valuation ($) 396.3 b | Valuation ($) 27.1 b | Valuation ($) 163.9 b | Valuation ($) 70.8 b | Valuation ($) 71.6 b | Valuation ($) 20.8 b |
Financial | ||||||||||||
Revenue (est.) | Revenue (est.) $1.1b (FY, 2023) | Revenue (est.) $8.8b (FY, 2023) | Revenue (est.) €43.1b (FY, 2023) | Revenue (est.) $8.5b (FY, 2023) | Revenue (est.) £30.3b (FY, 2023) | Revenue (est.) $34.1b (FY, 2023) | Revenue (est.) $85.2b (FY, 2023) | Revenue (est.) €47.6b (FY, 2023) | Revenue (est.) $58.5b (FY, 2023) | Revenue (est.) $357.8b (FY, 2023) | Revenue (est.) €21b (FY, 2023) | Revenue (est.) $15.8b (FY, 2023) |
Cost of goods | Cost of goods $540.6m (FY, 2023) | Cost of goods $1.3b (FY, 2023) | Cost of goods €12.5b (FY, 2023) | Cost of goods $2.6b (FY, 2023) | Cost of goods £5.8b (FY, 2023) | Cost of goods $7.1b (FY, 2023) | Cost of goods $26.6b (FY, 2023) | Cost of goods €7b (FY, 2023) | Cost of goods $25b (FY, 2023) | Cost of goods $217.1b (FY, 2023) | Cost of goods €7.3b (FY, 2023) | Cost of goods $8.2b (FY, 2023) |
Gross profit | Gross profit $588.6m (FY, 2023) | Gross profit $7.5b (FY, 2023) | Gross profit €34.5b (FY, 2023) | Gross profit $6b (FY, 2023) | Gross profit £25.7b (FY, 2023) | Gross profit $27b (FY, 2023) | Gross profit $58.6b (FY, 2023) | Gross profit €42.1b (FY, 2023) | Gross profit $33.5b (FY, 2023) | Gross profit $140.7b (FY, 2023) | Gross profit €13.9b (FY, 2023) | Gross profit $7.6b (FY, 2023) |
Net income | Net income ($533.1m) (FY, 2023) | Net income ($611m) (FY, 2023) | Net income €5.6b (FY, 2023) | Net income $2.3b (FY, 2023) | Net income £5.3b (FY, 2023) | Net income $5.2b (FY, 2023) | Net income $35.2b (FY, 2023) | Net income (€2.9b) (FY, 2023) | Net income $2.2b (FY, 2023) | Net income $8.4b (FY, 2023) | Net income €2.8b (FY, 2023) | Net income ($615m) (FY, 2023) |
Operating ⚠ | ||||||||||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 100 (Q3, 2021) | Countries 92 (FY, 2021) | Countries 120 (FY, 2021) | Countries N/A | Countries 83 (FY, 2021) | Countries 125 (FY, 2021) | Countries N/A | Countries 66 (FY, 2021) | Countries N/A |
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 29 (FY, 2020) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 39 (FY, 2021) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 16 (FY, 2021) | Phase I Trials Products 27 (FY, 2019) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 27 (FY, 2021) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2021) | Phase II Trials Products 8 (FY, 2021) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 25 (FY, 2021) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2021) | Phase III Trials Products 10 (FY, 2021) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 27 (FY, 2021) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A |
Products | Products N/A | Products 1.4 k (FY, 2019) | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products 300 k (FY, 2021) | Products N/A |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 225 (FY, 2019) | Projects in R&D Pipeline 91 (FY, 2019) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A |
R&D Facility Space, sq. ft. | R&D Facility Space, sq. ft. N/A | R&D Facility Space, sq. ft. N/A | R&D Facility Space, sq. ft. N/A | R&D Facility Space, sq. ft. 1.6 m (FY, 2020) | R&D Facility Space, sq. ft. N/A | R&D Facility Space, sq. ft. 4.4 m (FY, 2021) | R&D Facility Space, sq. ft. N/A | R&D Facility Space, sq. ft. N/A | R&D Facility Space, sq. ft. N/A | R&D Facility Space, sq. ft. N/A | R&D Facility Space, sq. ft. N/A | R&D Facility Space, sq. ft. N/A |
Suppliers | Suppliers N/A | Suppliers N/A | Suppliers 68 k (FY, 2019) | Suppliers N/A | Suppliers 37.5 k (FY, 2021) | Suppliers N/A | Suppliers N/A | Suppliers 93.8 k (FY, 2021) | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A |
Trademarks | Trademarks N/A | Trademarks 170 (Feb, 2021) | Trademarks N/A | Trademarks 8.2 k (FY, 2020) | Trademarks N/A | Trademarks N/A | Trademarks N/A | Trademarks 1.5 k (FY, 2021) | Trademarks N/A | Trademarks N/A | Trademarks N/A | Trademarks N/A |
Funding | ||||||||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 310m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 3.5b | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 121m | Total funding raised $ 358m |
For sources of this data, please see the company profile
View Company Profiles
Bausch Health
HQ
Laval, CA
Employees
20,270
Bausch Health is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products.
View companySanofi
HQ
Paris, FR
Employees
86,088
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View companyZoetis
HQ
Parsippany, US
Employees
14,100↑ 2% increase
Zoetis (formerly known as Pfizer Animal Health) is an animal health company focusing on the discovery, development, manufacture, and commercialization of medicines, vaccines, and diagnostic products and services.
View companyGSK
HQ
Brentford, GB
Employees
70,212
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company